Sort
64,565 grants matching “drug discovery”
Institutional Career Development Core
$1,468,751Emma Anne Meagher · University Of Pennsylvania · KL2 · FY2021 · TR
Cancer Research Center of Hawaii
$1,468,702Carl-Wilhelm E Vogel · University Of Hawaii At Manoa · P30 · FY2006 · CA
Raman Flow Cytometry for Diagnostics and Drug Discovery
$1,468,599La Jolla Bioengineering Institute · R01 · FY2004 · EB
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk
$1,468,531John Blangero · Texas Biomedical Research Institute · R01 · FY2013 · HL
Psychoactive Drug Effects on Brain Arachidonic Acid Signaling and Metabolism
$1,468,002Stanley I Rapoport · National Institute On Aging · ZIA · FY2013 · AG
A Translational Center for Barrier MPS
$1,467,307James L McGrath · University Of Rochester · U2C · FY2024 · AG
Functional Selectivity: A Novel Approach for CNS Drug Discovery
$1,466,420Bryan L Roth · Univ Of North Carolina Chapel Hill · U19 · FY2013 · MH
Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)
$1,466,401Kenneth W Turteltaub · University Of Calif-Lawrnc Lvrmr Nat Lab · P41 · FY2016 · GM
Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)
$1,466,401Kenneth W Turteltaub · University Of Calif-Lawrnc Lvrmr Nat Lab · P41 · FY2018 · GM
Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)
$1,466,401Kenneth W Turteltaub · University Of Calif-Lawrnc Lvrmr Nat Lab · P41 · FY2017 · GM
CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS
$1,465,763Doron Greenbaum · Phelix Therapeutics, Llc · R44 · FY2016 · AI
Regulatory landscape of the human genome: comparative and evolutionary analysis.
$1,465,659Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2018 · LM
Control of Oncogenic Signaling Through Spatial Organization of Kinases and mRNAs
$1,464,934Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Center for Biomolecular NMR Data Processing and Analysis
$1,464,071Jeffrey C Hoch · University Of Connecticut Sch Of Med/Dnt · P41 · FY2022 · GM
Discovery of functionally selective dopamine ligands for age-related cognitive decline
$1,464,036Yang Yang · Pennsylvania State Univ Hershey Med Ctr · RF1 · FY2021 · AG
Development of heparan sulfate-based therapeutics to treat inflammatory diseases
$1,463,275Zhangjie Wang · Glycan Therapeutics Corporation · R44 · FY2024 · GM
Biomolecular Structure and Mechanism, Structure-Based Drug Design
$1,463,239Xinhua Ji · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda
$1,462,907Matthew G Dorsey · University Of California, San Francisco · U19 · FY2010 · AI
Illuminating transcriptional condensates using an integrated approach
$1,462,500Liling Wan · University Of Pennsylvania · DP2 · FY2021 · HG
Preclinical development of a novel therapeutic for Parkinson's disease
$1,461,860Aarash Bordbar · Sinopia Biosciences, Inc. · R44 · FY2023 · NS
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,461,574Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
CHEMICAL GENETIC APPROACHES TO BASIC CELL BIOLOGY
$1,461,345Harvard University (Medical School) · P01 · FY2002 · GM
Human Genes Affecting Chromosome Metabolism and Stress Response
$1,461,318Michael A Resnick · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Translational and clinical studies targeting y-globin modulation
$1,461,194David A Williams · Boston Children'S Hospital · U01 · FY2015 · HL
Overcoming resistance to BRAF(V600E) targeted therapies in melanoma
$1,460,954David E Fisher · Massachusetts General Hospital · P01 · FY2013 · CA